Skip to main content

Advancing SARS-CoV-2 Vaccine and Therapeutic Development: Rapid and High Throughput Bioanalytical Tool for Immunogenicity and Titer Analysis

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • Robert Durham, Ph.D., Gyros Protein Technologies

    Dr. Rob Durham is currently the Director of Service and Scientific Support at Gyros Protein Technologies. He has been with the company since 2010 but prior to joining the company he was a Gyros customer as a Sr. Principal Scientist in Translational Medicine at Pfizer. Rob received his Ph.D. in Pharmacology and Neuroscience from Michigan State University and completed a postdoctoral fellowship at Parke Davis Pharmaceutical development before making the move to Pfizer. Exploring the ways immunoassay technologies can be applied to problems in bioanalysis and biotherapeutic drug development has been a major focus in his career.

November 11, 2020
Wed 10:00 AM EST

Duration 1H 30M

This live web event has ended.